Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
Go back to Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement| Asianada, Inc. (NASDAQ: ASND) | Delayed: 260.75 -0.83 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.58 | 52 Week High | $21.79 | |||
| Open | $261.82 | 52 Week Low | $11.92 | |||
| Day High | $268.94 | P/E | N/A | |||
| Day Low | $256.73 | EPS | $-0.07 | |||
| Volume | 4,450,794 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 56.23 +1.54 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $3.48 | |||
| Open | $54.60 | 52 Week Low | $0.80 | |||
| Day High | $56.29 | P/E | N/A | |||
| Day Low | $54.60 | EPS | $-1.54 | |||
| Volume | 6,979,834 | |||||

